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Objectives: Evaluation of the performance of a brief assessment tool for 
identifying substance use disorders. The Triage Assessment for Addictive 
Disorders (TAAD) is a triage instrument that provides professionals with a tool 
to evaluate indications of current substance use disorders in accordance with 
the DSM-IV diagnostic criteria. The TAAD is a 31-item structured interview 
that addresses both alcohol and other drug issues to discriminate among 
those with no clear indications of a diagnosis, those with definite, current 
indications of abuse or dependence, and those with inconclusive diagnostic 
indications. Methods: Employing a sample of 1325 women between the ages 
of 18 and 60, reliability estimates and problem profiles produced by the TAAD 
were evaluated. Results: The Cronbach alpha coefficients for internal 
consistency for both the alcohol and drug dependence scales were .92. The 
alpha coefficients for the alcohol and drug abuse scales were .83 and .84 
respectively. The diagnostic profiles elicited from the TAAD indicate that 
alcohol and drug dependences are the more definitive and distinct syndromes 
compared with the abuse syndromes. Discussion: The diagnostic profiles 
from this sample are consistent with previous research. The Cronbach alpha 
coefficients suggest that the TAAD provides an internally consistent index for 
alcohol and drug dependence and abuse. Implications for use in clinical 
practice and the need for further research regarding the psychometric 
properties of the TAAD are discussed.  
 
Since the 1940s, there has been a chasm between a narrow 
focus on alcoholism treatment and the treatment of “other” drugs. The 
days of separating alcohol from other drugs in terms of treatment 
needs, however, has passed. It is estimated that between 20% and 
43% of all substance abusers have a history of polysubstance use.1–3 
That is, they have used alcohol and some other drug such as 
marijuana, cocaine, amphetamines, or heroin. Compared with non-
treatment populations, the rate of polysubstance use is much greater 
for treatment populations with multiple drug use or dependence rates 
ranging from 50% to 90%.4,5 Therefore, treatment providers and 
referral sources such as social service agencies need to address issues 
related to both alcohol and other drugs.  
 
Identifying treatment needs is an ongoing process beginning 
with screening and, if indicated, follow-up with comprehensive 
assessment. Clinicians are encouraged to follow a decision-tree model 
that integrates diagnostic findings in determining treatment plans for 
alcohol and drug problems.6 This decision model consists of three 
phases: 1) screening; 2) comprehensive assessment; and 3) 
treatment planning. Each phase is interrelated and builds on the 
others, ultimately facilitating the best match between the client and 
the most appropriate treatment approach.  
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Screening is defined as the “skillful use of empirically based 
procedures for identifying individuals who have alcohol (or other drug) 
related problems or who are at risk for such difficulties”.7 Screens 
simply give a probability estimate that a given individual has or does 
not have a given condition. Thus, the primary objective of screening is 
to detect if an individual has a problem, appears to be developing one, 
or is not currently at any risk. This type of screening can be 
accomplished by using self-report questionnaires or brief interviews 
focusing on individuals’ patterns of problems related to substance use, 
and/or clinical laboratory tests to detect physiological cues of 
excessive alcohol or other drug consumption.8  
 
Numerous brief measures exist to screen for alcohol abuse or 
dependence. Two of the most widely used measures are the Alcohol 
Use Disorders Inventory Test (AUDIT)9,10 and the CAGE.11 Short 
screening instruments have also been developed for other drug abuse 
or dependence (e.g., Drug Abuse Screening Test [DAST]).11 Relatively 
few measures, however, have been developed to screen for both 
alcohol and other drugs (e.g., CAGE-AID, AUDIT-12; Chemical Use, 
Abuse and Dependence Scale).12-14 Longer screens such as the 
Michigan Alcoholism Screening Test (MAST)15 have the disadvantage of 
being lengthier but not providing more definitive information for 
documenting diagnostic indications according to current criteria or for 
covering drug as well as alcohol issues. Considering that the majority 
of people who are in need of treatment are polysubstance users, 
screening tools need to address both alcohol and other drugs.  
If a screening measure indicates a potential problem with alcohol or 
other drugs it is usually followed by a comprehensive assessment 
addressing biopsychosocial issues.16,17 Definitive diagnostic 
determinations require more extensive diagnostic tools for determining 
substance use disorder diagnoses in accordance with the DSM-IV.18,19 
Structured interviews, such as the Substance Use Disorder Diagnostic 
Schedule-IV20 and the Structured Clinical Interview for the DSM IV 
(SCID)21 can provide such definitive determinations. These 
determinations include both lifetime and current diagnoses for specific 
substances. However, these tools are lengthier, take at least half an 
hour or more to administer, and (in the case of the SCID) may require 
advanced training for the interviewer.  
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None of the available screens for substance use disorders 
document sufficient DSM-IV criteria to provide preliminary support for 
a dependence or abuse diagnosis. In this sense, the Triage 
Assessment for Addictive Disorders (TAAD)22 provides clinicians with 
more definitive information and greater support for identifying when a 
referral or definitive assessment should definitely be undertaken. In 
some cases, it can provide sufficient information for a preliminary 
current diagnosis.  
 
In choosing a diagnostic tool, treatment and allied health care 
providers need to decide which constructs need to be measured, what 
is the purpose of the measurement, and what resources are needed to 
employ the measure (in terms of time, cost, training, and expertise).8 
In this context, the TAAD fills a niche between the simple screen and 
the more comprehensive diagnostic interviews.  
 
Description of the Triage Assessment for Addictive 
Disorders (TAAD)  
 
The Triage Assessment for Addictive Disorders (TAAD) is a brief 
triage instrument that provides professionals with an efficient tool to 
evaluate current substance abuse problems in accordance with the 
DSM-IV diagnostic criteria. The TAAD is a 31-item structured interview 
that can be administered in 10 to 15 min, and addresses both alcohol 
and other drug issues. The TAAD is not intended to be a 
comprehensive diagnostic tool nor does it cover remission diagnoses. 
However, the TAAD is more than a screening tool in that it provides 
one of three findings:  
 
1. the individual has significant symptoms and behaviors so that a 
diagnosis can be documented with little, if any, additional 
assessment;  
2. the individual denies behaviors and events such that no 
diagnosis is indicated on the basis of the information; or  
3. the individual acknowledges indications of a diagnosis, but 
additional assessment is required to make a definitive 
determination.22  
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The TAAD items are directly based on the DSM-IV diagnostic 
criteria. These items cover behaviors and events consistent with the 
criteria for abuse and dependence of alcohol and other drugs. 
Accurately endorsing the TAAD items consequently should lead to the 
reliable identification of DSM-IV substance use disorder diagnoses 
relative to the last 12 months.  
 
The TAAD provides distinct profiles indicative of a dependence 
syndrome for either alcohol alone and for other drugs collectively. The 
majority of individuals who endorse items in three or more of the 
dependence categories present a clear constellation of problems 
compatible with a diagnosis of dependence. In contrast, those not 
meeting diagnostic criteria tend to clearly deny problems with alcohol 
or other drugs.23 The TAAD is currently being used in many treatment 
settings because of its clinical utility and ease of use. However, the 
psychometric properties of the TAAD need to be evaluated. The 
current study is a beginning to this evaluation.  
 
Methods  
 
Procedures  
 
Data for this study were derived from the routine use of the 
TAAD in screening individuals suspected of child abuse or neglect in an 
eastern state. Cases were flagged for completing the TAAD if there 
was any mention of substance abuse in the child abuse or neglect 
allegation or other reason to suspect any ongoing use. An evaluation 
could also be requested if the child was in foster care and the mother 
or father was being evaluated for readiness to resume custody of the 
child or children. Data for this study were provided as part of an 
evaluation of the TAAD as part of the routine screening in the 
agencies. All personal identifiers were removed from the data before 
being sent for data entry. Unfortunately, some demographic 
information such as ethnicity was also purged from the individual 
records (agencies did not have the resources to track down the purged 
data). Age, gender, and education level were the only demographic 
variables available.  
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Sample  
 
The sample used for these analyses consisted of 1,325 women 
between the ages of 18 and 60 who were referred to social service 
agencies in that state during 1998–1999 for child abuse issues or 
neglect. The sample was drawn from those women evaluated by the 
organization contracted to provide the evaluation and referral service 
for child abuse issues or neglect for the state. The mean age of the 
participants for the current study was 32.32 y (SD = 7.78). The mean 
number of years of education was 11.38 (SD = 1.75) with 46.8% not 
completing high school.  
 
Data regarding racial/ethnic identity was not available for this 
sample. However, this sample is reported by the agency to be similar 
to all of the clients served by this organization during these years. 
Although we did not have the statistics that could definitively be 
matched to the cohort, statistics from one quarter were available for a 
limited comparison to the sample used in this study. Based on data 
from a representative quarter (December 1997 through February 
1998) 253 cases were referred for evaluation. Of these, 176 (69%) 
were African American, 40 (16%) were Hispanic, and 37 (15%) were 
Caucasian. The average age was 32 and the median was 30 years of 
age. Most of the participants were poorly educated and on assistance 
at the time of the allegation of abuse or neglect. The allegations of 
abuse or neglect tended to be on the most recently born child. The 
mothers tended to have 2 to 3 children prior to the present case. The 
average years of alcohol or drug abuse was over 8 years. The overall 
demographics and other characteristics had been constant over time 
so that this quarter is likely to be fairly consistent with the 
characteristics of the sample in the current study.  
 
Scoring Algorithms  
 
The scoring algorithms for the TAAD were developed to classify 
individuals into diagnostic categories for abuse and dependence. 
Possible abuse is defined as a positive response to one or more items 
in any of the four abuse categories of the DSM-IV. Probable abuse is 
defined as having at least two different indications of abuse in one or 
more of the categories. Possible dependence is defined as having 
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problems endorsed in at least three of the seven dependence criteria 
of the DSM-IV. Probable dependence is defined as having at least 
three of the criteria covered plus having positive responses on at least 
five different dependence items. In other words a possible diagnosis 
meets the minimal DSM-IV criteria, but a probable diagnosis requires a 
more stringent criteria so that marginal cases are excluded.  
 
A diagnosis of dependence supercedes an abuse diagnosis. 
Therefore, the algorithm places individuals into the highest diagnostic 
category for which they qualify. For example, a classification of 
possible dependence constitutes a greater level of problems than 
probable abuse because probable dependence requires more 
diagnostic indications related to substance use than a probable abuse 
designation.  
 
For purposes of evaluating the performance of the TAAD in this 
study, we are not interested in estimating population base rates. 
Rather, we are interested in the ability of the TAAD to provide 
acceptable reliability estimates and diagnostic profiles that provide 
differentiation among those who appear to have no diagnosis, those 
who have only abuse indications, and those who appear to meet 
dependence criteria.  
 
Results  
 
The Cronbach alpha coefficients for internal consistency for both 
the alcohol and drug dependence scales were .92. The alpha 
coefficients for the alcohol and drug abuse scales were .83 and .84 
respectively. These statistics suggest that the TAAD provides an 
internally consistent index for alcohol and drug dependence and abuse. 
The somewhat higher coefficients for dependence would suggest that it 
might be the more pronounced syndrome.  
 
For this sample, the diagnostic distributions revealed a higher 
relative prevalence of dependence than abuse for both alcohol and the 
collective drug category (see Table 1). The “possible abuse” and 
“possible dependence” cases met the minimal possible criteria for the 
respective diagnosis. For abuse, this meant the individuals met only 
one abuse criterion; for dependence, the possible category cases met 
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only three of the dependence criteria. Those in the “probable” 
categories exceeded the minimal DSM-IV criteria.  
 
The striking pattern is that individuals tend to fall into either the 
“no diagnosis” or “probable dependence” categories for both alcohol 
and drugs. The abuse categories are relatively small as is the “possible 
dependence” group. The problem profiles reveal that the TAAD 
identifies a clear dependence syndrome for the vast majority of cases 
who meet at least minimal indications of dependence. For abuse, we 
find a less definitive constellation of problems. This would be 
consistent with the literature that suggests that dependence is the 
more definitive syndrome.24–26  
 
Of the individuals reaching a level of problems indicative of 
dependence, the vast majority reports criteria symptoms far in excess 
of the minimal diagnostic requirements. Sixty-one percent of all 
alcohol dependent cases (including both probable and definite) were 
positive on at least five of the seven dependence criteria. For drugs, 
70% of the drug dependent cases were positive on at least five of the 
DSM IV dependence criteria. In fact, 22% of the alcohol dependent 
individuals and 24% of the drug dependent cases report problems in 
all seven of the dependence criteria.  
 
In contrast, the majority of abuse cases are positive on 
relatively few of the four abuse categories. Of all alcohol abuse cases, 
74% are positive on only one of the four criteria, and for drugs, 82% 
are positive on only one criterion. None of the abuse cases for either 
alcohol or drugs were positive on all four of the abuse criteria.  
The column labeled “Maximum” in Table 1 is formed by placing each 
individual into the most serious diagnostic category based on either 
alcohol or drugs. Almost 80% of the sample falls into the “no 
diagnosis” or “probable dependent” category when both alcohol and 
drugs are considered. The remaining 21% fall into the other three 
diagnostic categories.  
 
A small proportion of the individuals with no diagnosis reported 
problems in two dependence criteria for either alcohol or drugs, but 
reported no abuse problems. These cases amounted to fewer than 6% 
of the total sample for alcohol and fewer than 3% for other drugs. 
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Overall, fewer than 4% of the cases have an ambiguity of diagnosis 
where the individual does not appear to meet DSM-IV criteria for a 
diagnosis, but reports more than one indication of dependence.  
Fewer than 2% of the sample met only one criterion for alcohol abuse 
in the absence of other abuse or dependence symptoms. For drugs this 
percentage was 2.3%. Overall, just under 3% met such minimal 
indications for abuse. Combining the proportion reporting problems but 
not meeting a diagnosis and the group meeting the most minimal 
criteria means that for the total sample only about 7% have serious 
ambiguities about whether a diagnosis is indicated.  
 
An analogous uncertainty exists for those who technically meet 
abuse criteria but also endorse two dependence criteria. Since the 
typical dependent individual also endorses abuse indications, one 
might also have concerns about those who meet minimal dependence 
criteria without endorsing other problems. Such marginal cases 
concerning abuse and dependence for alcohol account for fewer than 
5% of the sample. For drugs they account for a comparable 
proportion. When the substance categories are combined, 6% of the 
sample have some ambiguity between abuse and dependence for 
either alcohol or drugs.  
 
In short, relatively few cases (about 7%) had ambiguous 
indications of whether they might meet criteria for at least abuse. 
Similarly, a small minority (about 6%) presented symptoms where 
there was a question as to whether abuse or dependence was the 
most appropriate diagnosis.  
 
Discussion  
 
The internal consistency reliability estimates for the TAAD 
obtained with the study sample are quite good. This suggests that the 
TAAD provides internally consistent indices for alcohol abuse and 
dependence and for drug abuse and dependence. In this age of 
accountability and need for standardized diagnostic criteria, the TAAD 
shows promise as an efficient and useful triage tool that can be 
employed in initial assessments, determining need for treatment, and 
making referral decisions. Because the TAAD requires only 10 to 15 
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minutes for administration and scoring makes it attractive as a 
pragmatic tool for busy clinicians.  
 
While additional study of the psychometric properties of the 
TAAD is needed, it can be used by clinicians in several ways. 
Specifically, the TAAD can be used as part of a comprehensive 
assessment, to standardize initial diagnostic procedures, and to assist 
treatment planning by providing target areas for treatment (e.g., the 
TAAD can help identify problem areas related to drinking such as 
family or legal difficulties). Programmatically, the TAAD can be used by 
treatment programs to help standardize clinician assessment, reduce 
initial diagnostic variability due to clinical judgment, and provide useful 
information about diagnostic populations served. This information can 
be used by programs to advertise services, target funding, and in 
program development.  
 
The diagnostic profiles elicited from the TAAD indicating that 
alcohol and drug dependence are the more definitive syndromes 
compared with the abuse syndromes is consistent with previous 
research. This perspective does have theoretical implications as well as 
clinical implications, particularly in tailoring clinical services. For 
example, these findings bolster the argument that dependent 
individuals require more extensive and protracted services due to the 
greater extent and scope of problems. Conversely, briefer and less 
expensive services might be targeted to those confirmed as meeting 
abuse criteria.  
 
While the TAAD’s ability to identify and document positive 
dependence and abuse cases is impressive, this study was not able to 
definitively assess its sensitivity. It is possible that the TAAD failed to 
identify a number of individuals who consistently denied the problems 
and behaviors included in the TAAD, but still manifest a diagnosable 
substance use disorder. Comparisons of the TAAD findings with more 
comprehensive assessments, personal history, and biological tests 
would provide more definitive evidence of the instrument’s ability to 
accurately identify current substance use disorders. For example, 
comparing the TAAD and SUDDS-IV profiles from different studies 
suggest that the more extensive SUDDS-IV interview detects a greater 
range of problems,23 but these findings were not done on identical 
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cases or populations, so direct comparisons have not as yet been 
made. Additional evaluation of the construct validity of the TAAD is 
also needed.  
 
Another limitation of this study concerns the sample. The 
sample employed was not a randomly selected sample, but a 
convenience sample. Therefore the generalizability of the results to 
other populations may be limited. Evaluation of the reliability and 
validity of the data derived from the TAAD with other populations is 
needed to assess its utility in other populations. All psychometric 
properties apply to data and not to tests.27 That is, reliability and 
validity evidence are not characteristics of a test, but are functions of 
the data in hand. Researchers should always assess the psychometric 
properties in terms of their own data. Clinicians should do so as well. 
As clinical data are collected via standardized measures such as the 
TAAD, reliability estimates and assessment of the validity of the data 
can be done fairly easily with minimal consultation from researchers.  
Although additional study of the TAAD’s psychometric properties is 
warranted, these results suggest that TADD provides an internally 
consistent measure of substance use disorders that can be useful 
alone as a triage tool or as part of a more comprehensive assessment 
in both research and clinical practice. Its brevity makes the TAAD an 
attractive tool for initial determinations of whether further services or 
assessment are warranted.  
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Appendix  
 
Table 1: Prevalence of diagnostic categories as indicated by the TAAD 
(N = 1325) 
 
 
 
 
